Previous Close | 78.50 |
Open | 78.00 |
Bid | 75.00 x 10000 |
Ask | 80.50 x 10000 |
Day's Range | 77.50 - 78.50 |
52 Week Range | 58.50 - 89.50 |
Volume | |
Avg. Volume | 0 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Nitto Denko Avecia Inc. and Nitto Denko Avecia Pharma Services (Nitto Avecia), a global leader in contract development and manufacturing of oligonucleotides for the therapeutic market announced today that Tammy Cooper will be appointed President of Nitto Avecia effective June 21, 2024. Currently, Ms. Cooper is Vice President, Business Development and Project Management for Nitto Avecia. As President, she will report to Yoshihiko Terada who will be appointed Executive Chairman of Nitto Avecia. Th
OSAKA, Japan, November 09, 2023--Nitto Denko Corporation (TOKYO: 6988) (Headquarters: Osaka, Japan; President: Hideo Takasaki) (hereafter "Nitto"), together with the ATP, FITP (Italian Tennis and Padel Federation), and City of Turin, have launched a joint environmental sustainability project as part of its sponsorship of the Nitto ATP Finals, the finale of the ATP Tour season to be held from 12-19 November, 2023.